Patent details

1383515 Title: Activering van natuurlijke killercellen door adenosine-A3-receptoragonisten.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
1383515
WO Application Number:
IL02000298
Type:
European Patent Granted for NL
Status:
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Non-payment of the annual fee
Application number:
27264027
WO Publication Number:
WO02083152
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Israel (IL)
Publications:
EP1383515;

Dates

Filing date:
11/04/2002
Grant date:
15/12/2004
EP Publication Date:
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
15/12/2004
EP B1 Publication Date:
15/12/2004
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
15/03/2005
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
10/04/2022
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
01/11/2008

Applicant/holder

From:
15/12/2004
 
 

 

Name:
Can-Fite Biopharma Ltd.
Address:
Petach Tikva 49170, Israel (IL)

Domicile Holder

Name:
Dr. R. Jorritsma c.s.
From:
17/12/2004
Address:
N.V. Nederlandsch Octrooibureau, Postbus 29720, 2502 LS Den Haag, Netherlands (NL)
To:

Inventor

Name:
FISHMAN, Pnina
Address:
Israel (IL)

Priority

Priority Patent Number:
832818
Priority Date:
12/04/2001
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K31/52; A61K31/70; A61K31/7076;

Publication

Bulletin

1

Bulletin Heading:
VE4
Journal edition number:
200901
Publication date:
05/01/2009
Description:
Vervallen Europese octrooien wegens niet betalen van een jaarcijns

2

Bulletin Heading:
PE2
Journal edition number:
200506
Publication date:
01/06/2005
Description:
Verleende Europese octrooien die hebben voldaan aan art. 29P (ROW 1910) of art. 52 (ROW 1995)

3

Bulletin Heading:
PE3
Journal edition number:
200506
Publication date:
01/06/2005
Description:
Verleende Europese octrooien uit PE2 in alfabetische volgorde van namen van octrooihouders

4

Bulletin Heading:
PE1
Journal edition number:
200502
Publication date:
01/02/2005
Description:
Verleende Europese octrooien in nummervolgorde

Terms/Procedural Changes

Description:
Termijn voor indienen vertaling Europees octrooi [EN]
Date:
15/03/2005

Correspondence

1

Sent On Date:
06/11/2008
Letter Type:
Vervalbrief [EN]
Reference:
To:
Can-Fite Biopharma Ltd., 10 Bareket Street, Petach Tikva 49170, Israel (IL)

2

Received On Date:
15/03/2005
Letter Type:
Vertaling Europees octrooi [EN]
Reference:
--
From:
Dr. R. Jorritsma c.s., N.V. Nederlandsch Octrooibureau, Postbus 29720, 2502 LS Den Haag, Netherlands (NL)

3

Sent On Date:
17/12/2004
Letter Type:
Termijnbrief [EN]
Reference:
BULLETIN 0451
To:
Dr. R. Jorritsma c.s., N.V. Nederlandsch Octrooibureau, Postbus 29720, 2502 LS Den Haag, Netherlands (NL)

4

Sent On Date:
15/12/2004
Letter Type:
Termijnbrief [EN]
Reference:
BULLETIN 0451
To:
-

5

Received On Date:
30/11/2004
Letter Type:
Voorlopige domiciliekeuze [EN]
Reference:
---
From:
Dr. R. Jorritsma c.s., N.V. Nederlandsch Octrooibureau, Postbus 29720, 2502 LS Den Haag, Netherlands (NL)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
03/04/2007
Last Annual Fee Paid Number:
2
Payer:
Computer Patent Annuities
Filing date Document type Document Description Number of pages File Type
15/03/2005 Incoming Correspondence Paper 1 PDF /4/7/4/1/9/0700791474/migrated-docs/27264027_0_incomingcorrespondencepaper20050315.pdf
15/03/2005 Description 21 PDF /4/7/4/1/9/0700791474/migrated-docs/27264027_1_description20050315.pdf
15/03/2005 Claims 8 PDF /4/7/4/1/9/0700791474/migrated-docs/27264027_2_claims20050315.pdf
15/03/2005 Drawings 4 PDF /4/7/4/1/9/0700791474/migrated-docs/27264027_3_drawings20050315.pdf